Sawai Group Holdings Co., Ltd. revised consolidated earnings guidance for the fiscal year ending March 31, 2024. For the year, the company expects sales of JPY 180,000 million, operating profit of JPY 20,000 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5,957 JPY | +0.17% | +0.39% | +14.36% |
Apr. 03 | Sawai Group Finalizes Sale of US Subsidiary | MT |
Apr. 01 | Bora Pharmaceuticals Co., LTD. completed the acquisition of Sawai America Holdings Inc. from Sawai Group Holdings Co., Ltd.. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.36% | 1.66B | |
+25.83% | 661B | |
+27.00% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+13.09% | 231B | |
+5.46% | 200B | |
-9.61% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- 4887 Stock
- News Sawai Group Holdings Co., Ltd.
- Sawai Group Holdings Co., Ltd. Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2024